[
  {
    "ts": null,
    "headline": "Abbott (ABT) Laps the Stock Market: Here's Why",
    "summary": "Abbott (ABT) reached $134.59 at the closing of the latest trading day, reflecting a +1.2% change compared to its last close.",
    "url": "https://finnhub.io/api/news?id=52a47a9cdc7e23a69e18daa1241dd165a8c5fc9c813351c071029808ef38a275",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759528202,
      "headline": "Abbott (ABT) Laps the Stock Market: Here's Why",
      "id": 136980756,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott (ABT) reached $134.59 at the closing of the latest trading day, reflecting a +1.2% change compared to its last close.",
      "url": "https://finnhub.io/api/news?id=52a47a9cdc7e23a69e18daa1241dd165a8c5fc9c813351c071029808ef38a275"
    }
  },
  {
    "ts": null,
    "headline": "Top Stock Reports for AMD, Abbott & Micron Technology",
    "summary": "AMD, Abbott and Micron shine in fresh Zacks reports, highlighting AI momentum, product pipelines and strong financial positioning.",
    "url": "https://finnhub.io/api/news?id=4db71b71ff534af1f5f7620192044ed27429e306fe0f4c89847156c1a1f00d76",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759526640,
      "headline": "Top Stock Reports for AMD, Abbott & Micron Technology",
      "id": 136980721,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "AMD, Abbott and Micron shine in fresh Zacks reports, highlighting AI momentum, product pipelines and strong financial positioning.",
      "url": "https://finnhub.io/api/news?id=4db71b71ff534af1f5f7620192044ed27429e306fe0f4c89847156c1a1f00d76"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories stock underperforms Friday when compared to competitors despite daily gains",
    "summary": "Abbott Laboratories stock underperforms Friday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=895951f62039885efa3c438a4ab93eef3a2d3c8dc11d3890fb9a174d0f039610",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759509120,
      "headline": "Abbott Laboratories stock underperforms Friday when compared to competitors despite daily gains",
      "id": 136996365,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock underperforms Friday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=895951f62039885efa3c438a4ab93eef3a2d3c8dc11d3890fb9a174d0f039610"
    }
  },
  {
    "ts": null,
    "headline": "Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?",
    "summary": "The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
    "url": "https://finnhub.io/api/news?id=1072901e36250e74f5961d98cc941b9058886bfe73c785a262902912ab979dfb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759498202,
      "headline": "Abbott (ABT) Is Considered a Good Investment by Brokers: Is That True?",
      "id": 136980758,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The average brokerage recommendation (ABR) for Abbott (ABT) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?",
      "url": "https://finnhub.io/api/news?id=1072901e36250e74f5961d98cc941b9058886bfe73c785a262902912ab979dfb"
    }
  },
  {
    "ts": null,
    "headline": "Should Health Canada’s Approval of Abbott (ABT) Dissolvable Stent Drive a Rethink for Investors?",
    "summary": "Abbott Laboratories recently received Health Canada approval for the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind dissolvable stent designed to treat chronic limb threatening ischemia below the knee using a minimally invasive approach. This innovative device not only keeps arteries open and supports vessel healing, but also significantly reduces the need for repeat procedures in a condition with high rates of amputation and mortality. We'll explore how...",
    "url": "https://finnhub.io/api/news?id=854234ac9f836451690b65f785eaf65b2b44c70aad8370edbacd165a972b4598",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759494773,
      "headline": "Should Health Canada’s Approval of Abbott (ABT) Dissolvable Stent Drive a Rethink for Investors?",
      "id": 136964331,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories recently received Health Canada approval for the Esprit BTK Everolimus Eluting Resorbable Scaffold System, a first-of-its-kind dissolvable stent designed to treat chronic limb threatening ischemia below the knee using a minimally invasive approach. This innovative device not only keeps arteries open and supports vessel healing, but also significantly reduces the need for repeat procedures in a condition with high rates of amputation and mortality. We'll explore how...",
      "url": "https://finnhub.io/api/news?id=854234ac9f836451690b65f785eaf65b2b44c70aad8370edbacd165a972b4598"
    }
  },
  {
    "ts": null,
    "headline": "Medtronic wins CE mark for Penditure LAA exclusion device",
    "summary": "The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.",
    "url": "https://finnhub.io/api/news?id=50f442254ff2ec6a42cb44acf87c2269958c2382c2de1622871e1cf70a54d8b1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759485240,
      "headline": "Medtronic wins CE mark for Penditure LAA exclusion device",
      "id": 136965101,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.",
      "url": "https://finnhub.io/api/news?id=50f442254ff2ec6a42cb44acf87c2269958c2382c2de1622871e1cf70a54d8b1"
    }
  }
]